Kv1.3 in the spotlight for treating immune diseases DOI
María Navarro‐Pérez, Jesusa Capera, Anna Benavente-Garcia

et al.

Expert Opinion on Therapeutic Targets, Journal Year: 2024, Volume and Issue: 28(1-2), P. 67 - 82

Published: Feb. 1, 2024

Introduction Kv1.3 is the main voltage-gated potassium channel of leukocytes from both innate and adaptive immune systems. Channel function required for common processes such as Ca2+ signaling but also cell-specific events. In this context, alterations in are associated with multiple disorders. Excessive activity correlates numerous autoimmune diseases, while reduced currents result increased cancer prevalence immunodeficiencies.

Language: Английский

Microglial Phenotypic Transition: Signaling Pathways and Influencing Modulators Involved in Regulation in Central Nervous System Diseases DOI Creative Commons
Jiaxin Li, Xinyu Shui,

Ruizheng Sun

et al.

Frontiers in Cellular Neuroscience, Journal Year: 2021, Volume and Issue: 15

Published: Sept. 14, 2021

Microglia are macrophages that reside in the central nervous system (CNS) and belong to innate immune system. Moreover, they crucially involved CNS development, maturation, aging; further, closely associated with neurons. In normal conditions, microglia remain a static state. Upon trauma or lesion occurrence, can be activated subsequently polarized into pro-inflammatory anti-inflammatory phenotype. The phenotypic transition is regulated by numerous modulators. This review focus on literature regarding modulators signaling pathways regulating microglial transition, which rarely mentioned other reviews. Hence, this provides molecular insights could potential therapeutic target for neuroinflammation.

Language: Английский

Citations

58

Coumarins derivatives and inflammation: Review of their effects on the inflammatory signaling pathways DOI Creative Commons
Batoul Rostom, Racha Karaky, Issam Kassab

et al.

European Journal of Pharmacology, Journal Year: 2022, Volume and Issue: 922, P. 174867 - 174867

Published: March 3, 2022

Language: Английский

Citations

53

Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment DOI Creative Commons
Xiaoyi Chen, Yunjiang Feng, Ronald J. Quinn

et al.

Pharmacological Reviews, Journal Year: 2023, Volume and Issue: 75(4), P. 758 - 788

Published: March 14, 2023

Parkinson9s disease (PD) is a neurodegenerative disorder characterized by selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) region midbrain. The results subsequent reduction dopamine striatum, which underlies core motor symptoms PD. To date, there are no effective treatments to stop, slow, or reverse pathological progression neurodegeneration. This unfortunate predicament because current early stages understanding biological targets and pathways involved PD pathogenesis. Ion channels have become emerging for new therapeutic development due their essential roles neuronal function neuroinflammation. Potassium most prominent ion channel family been shown be critically important pathology modulating excitability, neurotransmitter release, synaptic transmission, In this review, members subfamilies voltage-gated K+ channels, inward rectifying Ca2+-activated potassium described. Evidence role these aetiology discussed together with latest views on related mechanisms potential as developing neuroprotective drugs Significance Statement second common disorder, featuring progressive degeneration It multifactorial involving multiple risk factors complex pathobiological mechanisms. Mounting evidence suggests that play vital pathogenesis regulating excitability immune cell function. Therefore, they "hot" PD, demonstrated clinical trials drug candidates targeting therapy.

Language: Английский

Citations

26

Voltage-gated potassium channel 1.3: A promising molecular target in multiple disease therapy DOI Open Access

Sixuan Cheng,

Dawei Jiang, Xiaoli Lan

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 175, P. 116651 - 116651

Published: April 30, 2024

Voltage-gated potassium channel 1.3 (Kv1.3) has emerged as a pivotal player in numerous biological processes and pathological conditions, sparking considerable interest potential therapeutic target across various diseases. In this review, we present comprehensive examination of Kv1.3 channels, highlighting their fundamental characteristics recent advancements utilizing inhibitors for treating autoimmune disorders, neuroinflammation, cancers. Notably, is prominently expressed immune cells implicated responses inflammation associated with diseases chronic inflammatory conditions. Moreover, its aberrant expression certain tumors underscores role cancer progression. While preclinical studies have demonstrated the efficacy inhibitors, clinical translation remains pending. Molecular imaging techniques offer promising avenues tracking assessing efficacy, thereby facilitating development application. Challenges future directions inhibitor research are also discussed, emphasizing significant targeting strategy spectrum

Language: Английский

Citations

13

Silibinin’s role in counteracting neuronal apoptosis and synaptic dysfunction in Alzheimer’s disease models DOI
Baohui Zhang, Di Zhang, Keyan Chen

et al.

APOPTOSIS, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 20, 2025

Language: Английский

Citations

1

Biotin mitigates the development of manganese-induced, Parkinson’s disease–related neurotoxicity in Drosophila and human neurons DOI Open Access
Yunjia Lai, Pablo Reina-Gonzalez,

Gali Maor

et al.

Science Signaling, Journal Year: 2025, Volume and Issue: 18(870)

Published: Jan. 21, 2025

Chronic exposure to manganese (Mn) induces manganism and has been widely implicated as a contributing environmental factor Parkinson’s disease (PD), featuring notable overlaps between the two in motor symptoms clinical hallmarks. Here, we developed an adult Drosophila model of Mn toxicity that recapitulated key parkinsonian features, spanning behavioral deficits, neuronal loss, dysfunctions lysosomes mitochondria. Metabolomics analysis brain body tissues these flies at early stage identified systemic changes metabolism biotin (also known vitamin B 7 ) Mn-treated groups. Biotinidase-deficient showed exacerbated Mn-induced neurotoxicity, parkinsonism, mitochondrial dysfunction. Supplementing diet wild-type with ameliorated pathological phenotypes concurrent Mn. Biotin supplementation also three standard fly models PD. Furthermore, supplementing culture media human induced stem cells (iPSCs) differentiated midbrain dopaminergic neurons protected against dysregulation, cytotoxicity, loss. Last, expression genes encoding biotin-related proteins patients PD revealed increased amounts transporters substantia nigra compared healthy controls, suggesting potential role altered Together, our findings underlying neurotoxicity pathology flies, for which dietary was preventative.

Language: Английский

Citations

1

Emerging Insights into Brain Inflammation: Stem-Cell-Based Approaches for Regenerative Medicine DOI Open Access
Marie Karam, Alba Ortega-Gascó, Daniel Tornero

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(7), P. 3275 - 3275

Published: April 1, 2025

Neuroinflammation is a complex immune response triggered by brain injury or pathological stimuli, and highly exacerbated in neurodegenerative diseases. It plays dual role the central nervous system, promoting repair acute stages while aggravating disease progression contributing to neuronal loss, synaptic dysfunction, glial dysregulation chronic phases. Inflammatory responses are mainly orchestrated microglia infiltrated monocytes, which, when dysregulated, not only harm existing neurons, but also impair survival differentiation of neural stem progenitor cells affected regions. Modulating neuroinflammation crucial for harnessing its protective functions minimizing detrimental effects. Current therapeutic strategies focus on fine-tuning inflammatory through pharmacological agents, bioactive molecules, cell-based therapies. These approaches aim restore homeostasis, support neuroprotection, promote regeneration various neurological disorders. However, animal models sometimes fail reproduce human-specific brain. In this context, stem-cell-derived provide powerful tool study neuroinflammatory mechanisms patient-specific physiologically relevant context. facilitate high-throughput screening, personalized medicine, development targeted therapies addressing limitations traditional models, paving way more effective treatments.

Language: Английский

Citations

1

Ion channels and transporters in microglial function in physiology and brain diseases DOI
Lanxin Luo, Shanshan Song,

Chibundum C. Ezenwukwa

et al.

Neurochemistry International, Journal Year: 2020, Volume and Issue: 142, P. 104925 - 104925

Published: Nov. 25, 2020

Language: Английский

Citations

59

Mitochondrial K+ channels and their implications for disease mechanisms DOI
Vanessa Checchetto, Luigi Leanza, Diego De Stefani

et al.

Pharmacology & Therapeutics, Journal Year: 2021, Volume and Issue: 227, P. 107874 - 107874

Published: April 27, 2021

Language: Английский

Citations

45

Microglia as Therapeutic Target for Radiation-Induced Brain Injury DOI Open Access
Qun Liu, Huang Yan, Mengyun Duan

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(15), P. 8286 - 8286

Published: July 27, 2022

Radiation-induced brain injury (RIBI) after radiotherapy has become an increasingly important factor affecting the prognosis of patients with head and neck tumor. With delivery high doses radiation to tissue, microglia rapidly transit a pro-inflammatory phenotype, upregulate phagocytic machinery, reduce release neurotrophic factors. Persistently activated mediate progression chronic neuroinflammation, which may inhibit neurogenesis leading occurrence neurocognitive disorders at advanced stage RIBI. Fully understanding microglial pathophysiology cellular molecular mechanisms irradiation facilitate development novel therapy by targeting prevent RIBI subsequent neurological neuropsychiatric disorders.

Language: Английский

Citations

37